5th Annual Advances In Immuno-Oncology Congress (Oxford Global) Virtual

Over 350 attendees representing global pharmaceutical organisations, leading biotech companies and internationally renowned academic and healthcare institutions developing immuno-oncology therapies and tools.

Over 60 presentations, case studies and panel discussions focussed on the key opportunities and challenges in immuno-oncology, from therapeutic strategies and biomarker development through to clinical research.

PLUS, interactive opportunities including:

  • Workshop on Accelerating the Treatment & Response Rate of Cancer Immunotherapies
  • roundtable discussions on key industry growth areas within immuno-oncology

View Agenda: https://bit.ly/2QbjKSV

Day One 

  • Discovery of Immuno-Oncology Therapies: Inhibitory Pathway & Cell-Based Approaches
  • Translational Immuno-Oncology
  • Personalised Therapies for Immuno-Oncology

Day Two 

  • Discovery of Immuno-Oncology Therapies: Antibody and Virus-Based Approaches
  • Preclinical Development: Screening, Assays and Modelling in Immuno-Oncology
  • Clinical Research & Trials in Immuno- Oncology